Compare KYMR & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYMR | WFRD |
|---|---|---|
| Founded | 2015 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.0B |
| IPO Year | 2020 | 2014 |
| Metric | KYMR | WFRD |
|---|---|---|
| Price | $84.73 | $92.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 8 |
| Target Price | ★ $108.04 | $97.50 |
| AVG Volume (30 Days) | 710.3K | ★ 1.1M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 5.93 |
| Revenue | $39,211,000.00 | ★ $4,331,000,000.00 |
| Revenue This Year | $16.05 | $0.37 |
| Revenue Next Year | $4.79 | $3.48 |
| P/E Ratio | ★ N/A | $15.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.45 | $36.74 |
| 52 Week High | $103.00 | $110.57 |
| Indicator | KYMR | WFRD |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 39.29 |
| Support Level | $66.33 | $82.22 |
| Resistance Level | $95.90 | $106.38 |
| Average True Range (ATR) | 4.53 | 3.77 |
| MACD | -0.97 | -2.17 |
| Stochastic Oscillator | 26.08 | 25.89 |
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.